thetaOwl

ORCL

Oracle CorporationClose $178.34EOD only
Max Pain
$150.00
Next expiry Apr 17, 2026
Expected Move
±$4.42
2.5% from close
Price Gap
-28.34
Distance to max pain
IV Rank
100
High premium
P/C OI
0.70
Slightly call-heavy
Consensus
6.5/10
Consensus signal
Published snapshot: Apr 16, 2026 close
End-of-day snapshot

This page reflects ORCL options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.

Published Snapshot
Apr 16, 2026 close
ORCL Directional Report
Analysis based on market close April 17, 2026

Historical consensus-supported lens with full content, report chain context, and metric rail.

Outlook

Moderately bullish: dealer short-gamma hedging and net-buy flow support continuation toward resistance band (~185–190); pinning risk from max-pain near 150–155 can compress upside if momentum fades.

Confidence:
8 / 10
GEX +$276M and dex buy flow drive dealer hedging (buying into rallies) supporting spot; offset by spot ~13% above midpoint and clustered max‑pain below spot increasing pin risk.
Supports: Dealer hedging buys on rallies, positive net buy flow, resistance cluster at 185–190.
Conflicts: Spot distance above MP and max‑pain pins at 150–155; limited nearby gamma protection if selling resumes.
🚀GEX +$276M with dex +68M shares → dealers hedging by buying into rallies, supporting price
📌Max‑pain at $150–155 creates asymmetric downside if hedging reverses
📈Near‑term range 165–185 with upside bias toward 185–190 if buyers continue

Regime Classification

Vol Regime
High
IV elevated vs recent norm but not extreme (VIX ~17).
Gamma Regime
Pinning
Dealers net short gamma (GEX +$276M); they buy underlying into rallies and sell into drops, creating pinning around option strikes.
Flow Regime
Bullish
Bullish net premium and dex buys indicate persistent buy pressure prompting dealer hedges.
Spot vs Max Pain
Above
Spot ~12.9% above midpoint; distance raises mean‑reversion and pin risk toward max‑pain.
Thesis duration: Multi-week — Sustained dealer short‑gamma hedging and consistent buy flow support a multi‑week biased setup

Price Range Forecast

Next 1 week
$165.06$185.06
Likely trade within 165–185; dealer hedges may cap downside near 165 if rallies persist
Next 2 weeks
$160.58$189.53
Upside to 185–190 possible; failure to hold 165 risks slide toward 160–155 max‑pain

Key Levels

Max pain pins: $155 (2026-04-17); $150 (2026-04-24); $150 (2026-05-01)
EM guardrails: 1w $165.06/$185.06
Support: $160.58
Resistance: $185.00 · $189.53 · $190.00
Structural: Support 160.58; guardrails 165.06 / 185.06; resistance cluster 185.0–190.0; max‑pain concentration ~150–155.

Dealer Positioning (GEX/DEX)

GEX: $+276.4M

DEX: +68.0M shares

Gamma flip: N/A

NTM gamma: GEX +$276.4M, dex +68M shares — dealers net short gamma and short delta exposure; hedging entails buying into rallies (support) and selling into drops (pin risk).

IV Analysis

IV vs VIX: Ticker IV richer than index VIX—options pricier than broad market, favoring directional hedged exposure over naked premium selling.

Term structure: Elevated near‑term IV with mild roll‑off; no major scheduled event kinks in next 2 weeks.

Skew: Put concentration below spot creates skew; consider directional call structures or defined flies to limit pin risk.

Flow Analysis

Net premium: Net premium ~+45.3M (positive = net premium received by sellers). This implies market-wide selling pressure (supports bullish delta if sellers are short calls), but interpretation depends on buy/sell-to-open split—confirm BTO/STO to know if premium was paid or collected.

Directional prints: 13.3 call 177.5 OTM 2026-04-17 — Very large intraday call block (23k vol, OI 2.9k) — likely aggressive call buying or large seller compression into close; bullish if BTO, bearish if STO. 6.8 put 175 OTM 2026-04-17 — Heavy same-day put volume (28k vol, OI 4k) — could be hedging or directional selling; side unclear without BTO/STO.

Unusual: 54.5 put 140 OTM 2026-05-22 — Very high vol/OI ratio on long-dated 140 puts — flags unusual activity but does not reveal trade-side; need block/BTO/STO records to infer directional exposure. 49.2 put 180 ITM 2026-04-24 — Elevated vol/OI at 180 puts indicating uncommon flow; cannot assume buyer direction without trade-side confirmation.

Risks & Catalysts

!Momentum reversal re-testing 160–155 max‑pain
!Sudden IV spike that reprices dealer hedges
!Broader market weakness eroding sector leadership

Strategy Viability

StrategyEdgeBest SetupPrimary Risk
Put credit spreadModerate-Strong
Sell 2026-06-18 $160.00/$155.00 put spread
Why now: Moderately bullish bias, dealer short-gamma and buy flow support upside; defined-risk premium sale monetizes elevated IV and net premium.
Pinning or momentum fade re-tests 155; sudden IV spike widens put prices.
Bull call spreadModerate
Buy 2026-06-18 $185.00/$190.00 call spread
Why now: Directional bullish lean with target into resistance band; debit spread controls cost while retaining upside exposure through earnings.
If momentum stalls or IV compresses post-earnings, spread may underperform; capped upside.
Put credit spreadModerate-Strong
Sell 2026-05-15 $160.00/$155.00 put spread
Why now: Moderately bullish bias with dealer short-gamma and net-buy flow; sell downside premium near max-pain band to earn yield if momentum continues.
IV spike or momentum reversal into 160–155 max-pain can force mark-to-market losses.
Bull call spreadModerate
Buy 2026-05-15 $170.00/$175.00 call spread
Why now: Directional long conviction over multi-week horizon; defined debit spread reduces cost vs naked call and benefits from rollable vega profile.
Limited upside if momentum stalls; moderate theta decay on long leg before move.
Call diagonalModerate-Strong
Sell 2026-05-01 $175.00 call / buy 2026-06-18 $180.00 call
Why now: Sell rich May near-term call (compression risk) and buy June call to keep upside exposure across earnings window if needed.
Near-term IV crush or large directional gap vs sold strike; calendar can flip if vol term-structure inverts.
Cash-secured putModerate
Sell 2026-06-18 $160.00 cash-secured put
Why now: Moderately bullish and willing to own shares near 155; choose post-earnings expiry to avoid forced unwind if thesis expects follow-through through earnings.
Assignment into broader market weakness or IV rise; capital tie-up until expiration.

Top Plays

#1
Sell Jun18 160/155 put credit
Sell 2026-06-18 $160.00/$155.00 put spread
Low‑risk premium sale that monetizes elevated IV and net premium while betting price stays above 160 into mid‑June.
Why this play: Collects premium with defined risk into multi‑week bullish thesis and dealer short‑gamma; expiry after earnings lets upside play out.
Credit: $1.60-$1.95
Max loss: $3.05
BE: $158.05
Mgmt: Close or roll if ORCL retests <160.50 or IV spikes; take max gain if spread value decays to bid within 2–3 weeks.
Yield/neutral‑bull traders wanting defined risk and theta income.
#2
Buy Jun18 185/190 call spread
Buy 2026-06-18 $185.00/$190.00 call spread
Debit spread captures upside toward resistance while limiting cost vs naked calls; benefits from momentum continuation.
Why this play: Directional play targeting resistance band (~185–190) with capped cost and upside through earnings.
Debit: $1.67-$2.04
Max loss: $2.04
BE: $187.04
Mgmt: Trim or take profit near 185–190; cut or roll if momentum fades or stock falls toward 160.
Directional bulls seeking leveraged upside with known max loss.
#3
May/Jun call diagonal (sell May175 / buy Jun180)
Sell 2026-05-01 $175.00 call / buy 2026-06-18 $180.00 call
Income‑plus‑carry structure that retains upside through earnings while harvesting May premium.
Why this play: Sells rich near‑term call to fund longer June upside exposure and leverages expected call compression in May.
Debit: $6.64-$8.11
Max loss: $8.11
BE: Path-dependent
Mgmt: Buy back short leg into heavy pinning/IV spike or roll short forward if positive momentum continues.
Traders wanting spread income plus continued upside exposure across earnings.

Watchlist Triggers

Entry Triggers
IFIF ORCL closes >165.06 on 1 trading dayTHEN sell Jun18 2026 160/155 put credit (s1) at target premium 1.60–1.95; size per risk limits
IFIF ORCL trades and closes >185.00 with momentum toward 189–190 clusterTHEN buy Jun18 2026 185/190 call spread (s2) at entry premium 1.67–2.04; trim into 185–190 resistance
Adjustment Triggers
ADJIF IV rises >20% vs 30‑day average OR s1 reaches 30% of max loss OR s2 mark loss >40% OR ORCL closes <185 for 1 dayTHEN for s1: buy back to cut loss or roll wider/down one strike; for s2: close or tighten to limit loss; if IV spike, consider buying protection (short‑dated puts) or reducing size

Tactical Summary

Moderately bullish into earnings (~54 days). Primary trade: defined‑risk put credit (s1) on confirmed close >165.06. Secondary: 185/190 call spread (s2) for upside. Use defined quantitative stop/hedge rules: IV spike >20% vs 30‑day avg, s1 max‑loss 30%, s2 loss >40%, or close <185 triggers adjustments.

Read the Directional analysis for ORCL for 2026-04-17. Each report is a market-close snapshot with regime read, key levels, and strategy context that translates options positioning into an actionable setup.